Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis

Iranian Journal of Pediatrics

Volumn 20, Issue 1, 2010, Pages 41-47

  Boskabadi, Hassan ^a   Maamouri, Gholamali ^a   Afshari, Jalil Tavakol ^b   Ghayour Mobarhan, Majid ^c   Shakeri, Mohammad Taghy ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Interleukin 8; Laboratory marker; Newborn; Sepsis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8;

ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; SCREENING; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 77749314925     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nupponen I, Andersson S, Järvenpää A, et al. Neutrophil CD11b expression and circulating Interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics. 2001;108(1): 12-8.
2. Franz AR, Bauer K, Schalk A, et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics. 2004;114(1):1-8.
3. Maamouri GH, Boskabadi H, Tavakkol Afshari J, Shakeri MT. Evaluation of quantitative IL6 in the diagnosis of neonatal sepsis. J Mashhad Univ Med Sci. 2006;49(93):253-6.
4. Verboon-Maciolek MA, Thijsen SF, Hemels MA, et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res. 2006;59(3):457-61.
5. Murray B. Can antibiotic resistance be controlled? N Engl J Med. 1994;330(17):1229-30.
6. Berger C, Uehlinger J, Ghelfi D, et al. Comparison of C reactive protein and white blood cell count with differential in neonates at risk of septicaemia. Eur J Pediatr. 1995;154(2):138-44.
7. Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr. 1988;112(5):761-7.
8. Wagle SGA, Kohan R, Evans SF. C-reactive protein as a diagnostic tool of sepsis in very immature babies. J Paediatr Child Health. 1994; 30(1):40-4.
9. Gonzalez BE, Mercado CK, Johnson L, Brodsky NL. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med. 2003;31(1):60-8.
10. Baier RJ, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med. 2006;12(4):10-6.
11. Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal. 1997;77(3):221-7.
12. Maamouri GH, Boskabadi H, Tavakkolafshari J, Shakeri MT. Evaluation Quantities Interleukin 6 in diagnosis of Neonatal sepsis . Medical Journal of Mashad University of Medical Sciences 2006; 93(49): 253-260.
13. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infant. Pediatr Infect Dis J. 1998; 17(7):593-8.
14. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal. 2006;91(3):208-12.
15. Horisberger T, Harbarth S, Nadal D, et al. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial. Crit Care. 2004;8(6):443-50.
16. Magudumana MO, Ballot DE, Cooper PA, et al. Serial interleukin 6 measurements in the early diagnosis of neonatal sepsis. J Trop Pediatr. 2000;46(5):267-71.
17. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr. 2006;18(2):125-31.
18. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin 8 and C-reactive protein as markers of bacterial infections. Pediatrics. 1999;104(3):447-53.
19. Franz AR, Kron M, Pohlandt F, Steinbach G. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J. 1999;18(8):666-71.
20. Kocabaş E, Aysun S, Necmi A. Role of procalcitonin, C reactive protein, interleukin 6, interleukin-8 and tumor necrosis factor-α in the diagnosis of neonatal sepsis. Turk J Pediatr. 2007;49(1):7-20.
21. Edgar JD, Wilson DC, McMillan SA, et al. Predictive value of soluble immunological mediators in neonatal infection. Clin Sci. 1994; 87(2):165-71.
22. Chiesa C, Pellegrini G, Panero A, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem. 2003; 49(1):60-8.
23. Schollin J. Interleukin-8 in neonatal sepsis. Acta Paediatr. 2001;90(9):961-2.
24. Tryzmel J, Miskolci V, Castro-Alcaraz S, et al. Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B. Pediatr Res. 2003;54(3):382 6.